2010
DOI: 10.1590/s0066-782x2010000100004
|View full text |Cite
|
Sign up to set email alerts
|

Estudo de mutações causadoras de cardiomiopatia hipertrófica em um grupo de pacientes no Espírito Santo, Brasil

Abstract: Background: Hypertrophic cardiomyopathy (HC) is the most frequent cardiac hereditary disease, caused by mutations in sarcomere protein coding genes. Although more than 4 0 mutations have been identified in several continents and countries, there have been no reports of mutations in Brazil.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 26 publications
0
2
0
1
Order By: Relevance
“…This review will focus on the molecular mechanisms of HCM, the pathways from mutation to clinical phenotype and how the disease's genotype correlates with phenotype. Moreover, we will show recent data on the genetic profile of HCM patients on in the Brazilian population 1,3 .…”
Section: Introductionmentioning
confidence: 96%
“…This review will focus on the molecular mechanisms of HCM, the pathways from mutation to clinical phenotype and how the disease's genotype correlates with phenotype. Moreover, we will show recent data on the genetic profile of HCM patients on in the Brazilian population 1,3 .…”
Section: Introductionmentioning
confidence: 96%
“…In the last three years, we selected five original contributions, regardless of the studies' areas of investigation. During this period, the award was presented to three original articles in the area of arterial hypertension [1][2][3] , three articles on heart failure and cardiomyopathies [4][5][6] , three articles related to cardiovascular surgery [7][8][9] , two articles in basic and experimental research 10,11 , and one article in the areas of arrhythmia 12 , epidemiology 13 , exercise and rehabilitation 14 and coronary failure 15 , respectively.…”
mentioning
confidence: 99%
“…Em contraposição a esta primeira relação fenotípica, Ackerman e cols (2002) descreveram a mesma alteração em um paciente com hipertrofia severa e sua mãe, apesar de ter a mesma mutação, apresentava hipertrofia discreta. Estes mesmos aspectos foram discutidos em um trabalho nacional (Marsiglia, 2010), em um paciente com hipertrofia moderada e síncope, apresentação mais concordante com as características clínicas do paciente que apresentou esta mutação como causadora de doença no presente estudo.…”
Section: Perfil Genéticounclassified